A pair of Oklahoma City facilities home to biopharmaceutical company Cytovance Biologics have traded hands in an $11.75 million deal.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Cytovance Biologics
100 30th St, Oklahoma City, OK
- Companies
- Contacts
- Jon Sellers
Principal, Revko Commercial Real Estate
- Brett Price
Senior Managing Director, Newmark Robinson Park